Insider Trades21 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Sell | RNAC | Milos Miljkovic | Chief Medical Officer | 3,573 | $6.82 | $242.7M | -43.27% | +47.50% | $24.4K | -5.73% | — | Stalk |
| Jan 6, 2026 | Sell | RNAC | Blaine Davis | Chief Financial Officer | 10,591 | $6.82 | $242.7M | -43.27% | +47.50% | $72.2K | -8.03% | — | Stalk |
| Jan 6, 2026 | Sell | RNAC | Carsten Brunn | President and CEO | 23,766 | $6.82 | $242.7M | -43.27% | +47.50% | $162.1K | -6.84% | — | Stalk |
| Dec 30, 2025 | Buy | RNAC | Emily English | Chief Operations Officer | 7,500 | $3.30 | $242.7M | -43.27% | +47.50% | $24.8K | +9.14% | — | Stalk |
| Nov 28, 2025 | Buy | RNAC | Emily English | Chief Operations Officer | 7,500 | $3.30 | $242.7M | -43.27% | +47.50% | $24.8K | +9.14% | — | Stalk |
| May 12, 2025 | Buy | RNAC | Emily English | Chief Operations Officer | 7,500 | $3.30 | $242.7M | -43.27% | +47.50% | $24.8K | +9.14% | — | Stalk |
| Apr 15, 2025 | Buy | RNAC | Emily English | Chief Operations Officer | 7,500 | $3.30 | $242.7M | -43.27% | +47.50% | $24.8K | +9.14% | — | Stalk |
| Jan 10, 2025 | Buy | RNAC | Christopher M Jewell | Chief Scientific Officer | 9,000 | $3.23 | $242.7M | -43.27% | +47.50% | $29.1K | +7.44% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Emily English | Chief Operations Officer | 1,797 | $16.78 | $242.7M | -43.27% | +47.50% | $30.1K | -2.16% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Milos Miljkovic | Chief Medical Officer | 1,880 | $16.78 | $242.7M | -43.27% | +47.50% | $31.5K | -2.55% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Christopher M Jewell | Chief Scientific Officer | 2,550 | $16.78 | $242.7M | -43.27% | +47.50% | $42.8K | -2.30% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Metin Kurtoglu | Chief Technology Officer | 4,875 | $16.78 | $242.7M | -43.27% | +47.50% | $81.8K | -3.70% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Blaine Davis | Chief Financial Officer | 7,989 | $16.78 | $242.7M | -43.27% | +47.50% | $134.0K | -3.96% | — | Stalk |
| Jan 3, 2025 | Sell | RNAC | Carsten Brunn | President and CEO | 17,271 | $16.78 | $242.7M | -43.27% | +47.50% | $289.8K | -3.98% | — | Stalk |
| Dec 26, 2024 | Buy | RNAC | Emily English | SVP, Head of Manufacturing | 7,650 | $3.30 | $242.7M | -43.27% | +47.50% | $25.2K | +11.31% | — | Stalk |
| Dec 9, 2024 | Sell | RNAC | Metin Kurtoglu | Chief Technology Officer | 27,328 | $13.33 | $242.7M | -43.27% | +47.50% | $364.4K | +0.00% | — | Stalk |
| Nov 20, 2024 | Buy | RNAC | Christopher M Jewell | Chief Scientific Officer | 14,000 | $3.23 | $242.7M | -43.27% | +47.50% | $45.2K | +13.68% | — | Stalk |
| Nov 19, 2024 | Sell | RNAC | Metin Kurtoglu | Chief Technology Officer | 77,378 | $9.09 | $242.7M | -43.27% | +47.50% | $703.6K | +0.00% | — | Stalk |
| Nov 14, 2024 | Sell | RNAC | Christopher M Jewell | Chief Scientific Officer | 104,230 | $10.01 | $242.7M | -43.27% | +47.50% | $1.0M | +0.00% | — | Stalk |
| Nov 14, 2024 | Sell | RNAC | Milos Miljkovic | Chief Medical Officer | 110,000 | $9.87 | $242.7M | -43.27% | +47.50% | $1.1M | +0.00% | — | Stalk |
| Nov 14, 2024 | Sell | RNAC | Metin Kurtoglu | Chief Technology Officer | 164,736 | $9.43 | $242.7M | -43.27% | +47.50% | $1.6M | +0.00% | — | Stalk |